Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial
Sydney-based Recce Pharmaceutical Ltd (ASX:RCE) has reached a landmark stage in its…
Recce Pharmaceuticals Ltd (ASX:RCE)
About Recce Pharmaceuticals Ltd
Key Information
RCE In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 09/12/2024 | Price Sensitive PS Regulatory Approval for Registrational Phase 3 R327G Trial | 265.32KB | 11K |
| 05/12/2024 | Price Sensitive PS Trading Halt | 567.51KB | 8.9K |
| 28/11/2024 | Presentation - Ord Minnett Biotech & MedTech Conference | 2.46MB | 1.5K |
| 26/11/2024 | Price Sensitive PS Australia Patent Granted for RECCE Anti-Infectives | 213.38KB | 1.8K |
| 21/11/2024 | Change of Director's Interest Notices | 1.34MB | 3.3K |
| 21/11/2024 | Notification regarding unquoted securities - RCE | 19.34KB | 589 |
| 14/11/2024 | Price Sensitive PS AUD $6.75m R&D Rebate Approved | 208.49KB | 5.4K |
| 13/11/2024 | Notification regarding unquoted securities - RCE | 18.34KB | 368 |